In Vitro Diagnostics - Global Market Outlook (2018-2027)

According to Stratistics MRC, the Global In Vitro Diagnostics Market is accounted for $87.93 billion in 2018 and is expected to reach $164.40 billion by 2027 growing at a CAGR of 7.2% during the forecast period. Increasing adoption of fully automated instruments in labs, rising awareness on personalized medicine and consequent growth of chronic diseases are the major factors driving the market growth. However, adverse reimbursement scenario is restraining the market growth.

In Vitro Diagnostics (IVD) consists of medical devices and consumables that are utilized to detect any kind of infection and diseases by taking the specimen from the human body to cure diseases or its sequelae and perform in vitro tests on various biological samples. These products can be instruments, reagents, or any system used for the diagnosis of diseases. They are used for the diagnosis of various medical conditions, such as diabetes and cancer.

Based on end user, the point-of-care testing segment is likely to have a huge demand due to rising requirements of these testing’s as it includes biosensors, pregnancy kits and glucose meters to ensure quick and accurate results. By geography, North America is going to have a lucrative growth during the forecast period due to awareness among people regarding availability of innovative products and upsurge of strong prominent business players will lead to market growth.

Some of the key players profiled in the In Vitro Diagnostics Market include Abbott Laboratories Inc, Agilent Technologies, Becton Dickinson and Company, Biomérieux Sa, Bio-Rad Laboratories Inc, Cepheid, Danaher Corporation, Diasorin, Johnson & Johnson, Leica Biosystems Nussloch GmbH, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific.

Usability’s Covered:
• Reusable IVD Devices
• Disposable IVD Devices

Products Covered:
• Data Management Software
• Reagents & Kits
• Services
• Instruments   

Technologies Covered:
• Blood Testing
• Coagulation and Hemostasis
• Hematology
• Immunohematology
• Microbiology
• Tissue Diagnostics
• Urinalysis
• Clinical Chemistry
• Molecular Diagnostics
• Immunoassay/Immunochemistry

Applications Covered:
• Autoimmune Diseases
• Cardiology
• Diabetes
• Drug Testing/Pharmacogenomics
• Endocrinology
• Gastrointestinal Diseases
• HIV/Aids
• Infectious Diseases
• Nephrology
• Non Infectious Diseases
• Oncology   

End Users Covered:
• Academic Institutes
• Home Care
• Hospitals
• Patient Self-Testing
• Point-Of-Care Testing
• Laboratories

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances